ABSCI CORP Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABSCI CORP stock issued during period, value, new issues for the quarter ending 2026-06-30 was $98.14M.
- ABSCI CORP stock issued during period, value, new issues for the quarter ending 2026-03-31 was $7.96M, a 79.68% decline year-over-year.
- ABSCI CORP stock issued during period, value, new issues for the quarter ending 2025-09-30 was $60.65M.
- ABSCI CORP stock issued during period, value, new issues for the quarter ending 2025-03-31 was $39.16M, a 51.55% decline year-over-year.
- ABSCI CORP stock issued during period, value, new issues for fiscal 2025 was $103.31M, a 25.37% increase from fiscal 2024.
- ABSCI CORP stock issued during period, value, new issues for fiscal 2024 was $82.40M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $98.14M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $7.96M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $103.31M 10-K · filed 2026-03-24 | |
| 2025-09-30 | $60.65M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $39.16M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $82.40M 10-K · filed 2026-03-24 | |
| 2024-03-31 | $80.83M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |